Biotechnology

Bioeconomy in India is growing: the sector expanding to $165.7 billion in 2024 from just $10 billion in 2014

Il BioeconomistaLeave a comment

According to the India Tribune, “over the past decade, India has emerged as one of the fastest-growing bioeconomies in the world, with the sector expanding to $165.7 billion in 2024 from just $10 billion in 2014”. With an ambitious target of $300 billion by 2030, the bioeconomy is steadily becoming a cornerstone of India’s sustainable growth and innovation, driven by advancements in biotechnology, agricultural innovation, biomanufacturing, and healthcare. Indeed in the concept of bioeconomy in India the biopharmaceuticals is also included.

Continue reading →

Toyobo and DMC Sign JDA to Advance Sustainable Chemical Solutions

Il BioeconomistaLeave a comment
Jim Flatt, CEO DMC Biotechnologies

DMC Biotechnologies, Inc. and Toyobo Co., Ltd. entered into a multi-year collaboration agreement to develop a more sustainable, fermentation-produced, high volume chemical intermediate for use in a wide range of essential materials. This partnership brings together DMC’s expertise in precision fermentation with Toyobo’s extensive chemical and biotechnology process knowledge, along with their broad access to global markets.

Continue reading →

An exclusive interview with Gregory Jaffe (former USDA). “The Trump Administration will need to ensure the US has an enabling environment that supports the bioeconomy”

Il BioeconomistaLeave a comment

Gregory Jaffe was Senior Advisor for Regulatory Affairs in the Office of the Secretary at USDA during the Biden Administration. He is now Founder and President of a policy consulting firm based in Washington DC, specializing in agriculture, food, environmental, and climate policy, both domestic and international.

In this exclusive interview with Il Bioeconomista, he talks about the prospects for the bioeconomy in the United States under the new Trump Administration and the relations between the United States and the European Union in this new era of tariffs.

“The Trump Administration – Jaffe says – will need to ensure the United States has an enabling environment that supports biotechnology, biomanufacturing, and the bioeconomy”.

Interview by Mario Bonaccorso

Continue reading →

Bioeconomy on the rise: Momentum building amid global challenges

Il BioeconomistaLeave a comment
European Parliament, Brussels

We are navigating turbulent times, yet the bioeconomy continues to gain momentum, demonstrating its resilience and relevance across the globe. In just the past month, we have seen remarkable developments from various regions – each reinforcing the growing recognition of bio-based solutions as a pathway to sustainability and economic transformation. Here are some of the latest developments shaping the future of the bioeconomy.

Continue reading →

An interview with Dirk Carrez, Executive Director of BIC (Biobased Industries Consortium).

Il BioeconomistaLeave a comment

“Currently, there are policy frameworks for food, feed and bioenergy, but not for bio-based chemicals and derived materials. This gap puts the bio-based chemicals and derived materials sector at a disadvantage, and has also an impact on investments in Europe.”. Dirk Carrez, executive director of BIC (Biobased Industries Consortium) talks to Il Bioeconomista.

Interview by Mario Bonaccorso

Continue reading →

Is Reims the capital of Champagne? Yes, but in March it will be also the capital of circular bioeconomy thanks to BioKET

Il BioeconomistaLeave a comment

IMG_0001

Reims is worldwide known as the capital of Champagne, the excellent sparkling wine that is made in the Champagne region of France using the traditional method (méthode traditionnelle). Founded by the Gauls, Reims became a major city in the Roman Empire and played later a prominent ceremonial role in French monarchical history as the traditional site of the coronation of the kings of France. From 19 to 21 March Reims will be also the capital of the industrial biotechnology and bio-based economy.

Continue reading →

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Il BioeconomistaLeave a comment
Novozymes
Novozymes Headquarter

There is a new company in the global bioeconomy: Novonesis. On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. All regulatory approvals and registrations are now in place and the proposed combination is successfully completed following the final registration with the Danish Business Authority.

Continue reading →

Lallemand completed acquisition of Evolva

Il BioeconomistaLeave a comment

68814488-6D16-4307-8C05-63E1BAF516D1

Lallemand Inc, a global leader within industrial biotechnology headquartered in Montreal (Canada), confirmed the closing in December 2023 of the acquisition by its subsidiary Danstar Ferment AG of Swiss biotechnology business Evolva AG from Evolva Holding AG. The transaction which was originally announced to the Swiss Stock Exchange on 21 November 2023 was approved by Evolva Holding shareholders at an extraordinary general meeting on 21st December 2023.

Continue reading →

L’Oréal and Geno create bio-based alternatives to key ingredients in beauty products

Il BioeconomistaLeave a comment
wp-image-799665490jpg.jpg
Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy

L’Oréal invested in a venture led by Geno, the California-headquartered biotechnology company, to create sustainable alternatives to key ingredients in beauty products. The French multinational company will be a founding member of the venture alongside Unilever and Kao.

Continue reading →

GFBiochemicals and BASF joined forces to develop sustainable solutions for chemicals

Il BioeconomistaLeave a comment
7A1F9E5D-5188-49A4-A84C-9AA4FE5EA5AD
Mathieu Flamini, CEO GFBiochemicals. In Greenland. Courtesy of Mathieu Flamini

After announcing its €15 million Serie A funding round, the sustainable chemical company GFBiochemicals entered into an agreement with German chemical giant BASF. Specifically, BTC Europe GmbH, BASF’s European distribution organization, and NXTLEVVEL Biochem, a joint venture and manufactoring arm of GFBiochemicals, signed an agreement on the distribution of biobased and biodegradable solvents derived from levulinic acid for the European market.

Continue reading →